Journal of Urologic Oncology

Renal Cell Carcinoma

Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study: Younsoo Chung, Seok-Soo Byun, Sung Kyu Hong, Sangchul Lee, Chang Wook Jeong, Seok Ho Kang, Sung-Hoo Hong, Ji Youl Lee, Yong-June Kim, Jinsoo Chung, Eu Chang Hwang, Tae Gyun Kwon, Jung Kwon Kim; Journal of Urologic Oncology. 2024;22(2):136-143. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800360018
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians: Bokyung Ahn, Jinahn Jeong, Yong Il Lee, Ja-Min Park, Sun Young Yoon, Cheryn Song, Yong Mee Cho; Journal of Urologic Oncology. 2024;22(2):115-127. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800440022
Cited By 1; Full text PubReader ePub PDF

Robot-Assisted Radical Nephrectomy With Inferior Vena Cava Thrombectomy: A Narrative Review With Step-by-Step Procedures: Seokhwan Bang, Sung-Hoo Hong; Journal of Urologic Oncology. 2024;22(2):105-114. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800420021
Cited By 1; Full text PubReader ePub PDF

A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting: Isamu Tachibana, Qian Qin, Jacob Taylor, Wadih Issa, Jeffrey Cadeddu, Vitaly Margulis, Tian Zhang; Journal of Urologic Oncology. 2024;22(2):100-104. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800500025
Cited By 1; Full text PubReader ePub PDF

Kidney Cancer

Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study: Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park; Journal of Urologic Oncology. 2024;22(1):59-67. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600660033
Cited By 1; Full text PubReader ePub PDF

Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center: Hyun Young Lee, Yunjoong Kim, Bumjin Lim, Dalsan You, Cheryn Song, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Jungyo Suh; Journal of Urologic Oncology. 2024;22(1):52-58. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600600030
Cited By 1; Full text PubReader ePub PDF

Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis: Jung Hoon Kim, Ji Woong Hwang; Journal of Urologic Oncology. 2024;22(1):42-51. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600120006
Cited By 1; Full text PubReader ePub PDF

Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis: Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, Myung Ha Kim, Jae Hung Jung, Mi Ah Han, Seung Hwan Lee, In Gab Jeong, Sun Il Kim, Eu Chang Hwang; Journal of Urologic Oncology. 2024;22(1):34-41. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600140007
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma

Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type: Chan Woo Wee, Jaeho Cho; Journal of Urologic Oncology. 2023;21(3):217-227. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600560028
Cited By 1; Full text PubReader ePub PDF

The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects: Hyerim Ha, Joo Han Lim; Journal of Urologic Oncology. 2023;21(3):208-216. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600540027
Cited By 1; Full text PubReader ePub PDF

Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis: Jin Noh, Sang Hun Song, Gyoohwan Jung, Sangchul Lee, Sung Kyu Hong, Seok Soo Byun, Jung Kwon Kim; Journal of Urologic Oncology. 2023;21(3):200-207. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600480024
Cited By 1; Full text PubReader ePub PDF

Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma: Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, Mehmet A. Bilen, Kenneth Ogan, Viraj A. Master; Journal of Urologic Oncology. 2023;21(3):183-199. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600500025
Cited By 2; Full text PubReader ePub PDF

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma

Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma: Dongsu Kim, Bumjin Lim, Jungyo Suh, Dalsan You, Cheryn Song, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn; Journal of Urologic Oncology. 2023;21(2):148-153. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.224400400020
Cited By 1; Full text PubReader ePub PDF

Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery?: Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, Eu Chang Hwang, Mi Ah Han, Jae Hung Jung, Hunju Lee, Myung Ha Kim, Cheol Kwak, Sun Il Kim, for the Korean Urologic Oncology Society Guideline Development Committee, Korean Renal Cancer Study Group; Journal of Urologic Oncology. 2023;21(2):140-147. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600180009
Cited By 1; Full text PubReader ePub PDF Supplementary Material

The Prognostic Significance of Body Mass Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma: Hee Jae Yoo, Sun Il Kim, Se Joong Kim, Il Won, Dae Sung Cho; Journal of Urologic Oncology. 2023;21(1):88-94. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.224400480024; Full text PubReader ePub PDF

5,578	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,030	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,372	The Present and Future of Intravesical Therapy in Bladder Cancer
4,321	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,296	Complex Epidemiology of Prostate Cancer in Asian Countries

Cited By 7	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Search